Video

Emerging Psychedelic Therapies

Author(s):

Alexander Somjen

Here's why psychedelics might be a valuable addition to mental health treatment.

Alexander Somjen discusses the fragmented psychedelic industry, regulatory frameworks, and potential commercial success.

Alexander Somjen is the CEO and Director of Origin Therapeutics.

Related Videos
brain
nicotine use
“What we’re striving to do is conquer the unmet needs that are still here with treating ADHD, especially from a medication standpoint.”
Work takes up one-third of a patient’s life—it is important that we pay attention to it.
Related Content
depression
December 18th 2024

IV Psilocin Benzoate for Major Depressive Disorder: New Phase 2a Results

Leah Kuntz
Here's to a Psychedelic Revolution
April 9th 2022

Here's to a Psychedelic Revolution

Amir Inamdar MBBS, DNB (Psych), MFPM
First Patient Dosed in Phase 3 Study of Psychedelic MM120 in Generalized Anxiety Disorder
December 17th 2024

First Patient Dosed in Phase 3 Study of Psychedelic MM120 in Generalized Anxiety Disorder

Megan McSweeney
How to Talk to Teenagers About Substance Use
October 8th 2021

How to Talk to Teenagers About Substance Use

Hannah Simon, MD
depression
December 4th 2024

Which Patients Respond to Ketamine vs ECT for Treatment-Resistant Depression?

Kenneth J. Bender, PharmD, MA
patients
November 26th 2024

Moving Along

Dinah Miller, MD
© 2024 MJH Life Sciences

All rights reserved.